DK173353B1 - Kapsel med nikotinholdigt flydende medium til oral indtagelse - Google Patents

Kapsel med nikotinholdigt flydende medium til oral indtagelse Download PDF

Info

Publication number
DK173353B1
DK173353B1 DK198803858A DK385888A DK173353B1 DK 173353 B1 DK173353 B1 DK 173353B1 DK 198803858 A DK198803858 A DK 198803858A DK 385888 A DK385888 A DK 385888A DK 173353 B1 DK173353 B1 DK 173353B1
Authority
DK
Denmark
Prior art keywords
capsule
nicotine
medium
liquid medium
containing liquid
Prior art date
Application number
DK198803858A
Other languages
Danish (da)
English (en)
Other versions
DK385888D0 (da
DK385888A (da
Inventor
Franz Adlkofer
Original Assignee
Forschungsgesellschaft Rauchen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forschungsgesellschaft Rauchen filed Critical Forschungsgesellschaft Rauchen
Publication of DK385888D0 publication Critical patent/DK385888D0/da
Publication of DK385888A publication Critical patent/DK385888A/da
Application granted granted Critical
Publication of DK173353B1 publication Critical patent/DK173353B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198803858A 1986-11-18 1988-07-08 Kapsel med nikotinholdigt flydende medium til oral indtagelse DK173353B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19863639418 DE3639418A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
DE3639418 1986-11-18
DE8700507 1987-11-06
PCT/DE1987/000507 WO1988003803A1 (en) 1986-11-18 1987-11-06 Oral administration capsule with a nicotine-containing fluid medium

Publications (3)

Publication Number Publication Date
DK385888D0 DK385888D0 (da) 1988-07-08
DK385888A DK385888A (da) 1988-07-08
DK173353B1 true DK173353B1 (da) 2000-08-07

Family

ID=6314221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803858A DK173353B1 (da) 1986-11-18 1988-07-08 Kapsel med nikotinholdigt flydende medium til oral indtagelse

Country Status (9)

Country Link
EP (1) EP0324794B1 (ja)
JP (1) JP2602043B2 (ja)
CN (1) CN87107852A (ja)
AT (1) ATE72114T1 (ja)
AU (1) AU622101B2 (ja)
BR (1) BR8707879A (ja)
DE (3) DE3645036A1 (ja)
DK (1) DK173353B1 (ja)
WO (1) WO1988003803A1 (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4440563A1 (de) * 1994-11-12 1996-05-15 Herzog Sen Rolf Verfahren und Mittel zum Genuß von Tabak - Nikotin unter Vermeidung schädlicher Verbrennungs - Derivate
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5846983A (en) * 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
AU2340397A (en) * 1996-03-21 1997-10-10 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6211194B1 (en) 1998-04-30 2001-04-03 Duke University Solution containing nicotine
US6268386B1 (en) * 1998-06-25 2001-07-31 Marshall Anlauf Thompson Nicotine beverage
GB2338896B (en) * 1998-07-02 2003-05-21 Reckitt & Colmann Prod Ltd Chewable Capsules
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
JP2003505507A (ja) 1999-07-28 2003-02-12 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 治療的血管新生および脈管形成におけるニコチン
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
SI1578422T1 (sl) 2002-12-20 2007-12-31 Niconovum Ab Fizikalno in kemiäśno stabilni nikotin in mikrokristal na celulozo vsebujoäś material iz trdnih delcev
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
WO2005007068A1 (en) * 2003-07-22 2005-01-27 The Kiwigel Company Limited Nicotine packaging system
NO20042835D0 (no) * 2004-07-05 2004-07-05 Nils-Erik Skeide Innkapslet tobakksroyk
CA2580329C (en) 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
EP2322167A1 (en) * 2007-04-02 2011-05-18 Parkinson's Institute Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
CN101249130B (zh) * 2008-04-11 2011-06-15 桂林商源植物制品有限公司 一种戒烟并缓解戒烟综合症的药用或保健组合物
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
WO2016145373A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
US10568852B2 (en) 2015-05-22 2020-02-25 Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Combination compositions and their use in methods for treating obesity and obesity-related disorders
CN105341990A (zh) * 2015-12-16 2016-02-24 浙江中烟工业有限责任公司 一种提升电子烟生理满足感的电子烟烟液
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (ja) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US3870794A (en) * 1974-02-20 1975-03-11 Foundation For Behavioral Rese Treatment of certain emotional disorders with nicotine compounds
GB1528391A (en) * 1976-01-05 1978-10-11 Gildemeister V Aerosol compositions
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
BE899037A (fr) * 1984-02-29 1984-06-18 Trenker Ady Composition a sucer permettant de cesser de fumer
DE3438284A1 (de) * 1984-10-16 1985-03-07 Hans-Harald von 2400 Lübeck Tilly Nikotinhaltiges depotpflaster
EP0186502A3 (en) * 1984-12-25 1986-12-10 Jano Tyroler Flavor capsule and method of preparing same
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment

Also Published As

Publication number Publication date
AU622101B2 (en) 1992-04-02
JPH02501304A (ja) 1990-05-10
AU8171287A (en) 1988-06-16
BR8707879A (pt) 1989-10-03
EP0324794B1 (de) 1992-01-29
DE3645036A1 (de) 1989-01-05
DE3639418A1 (de) 1988-06-09
EP0324794A1 (de) 1989-07-26
DE3776574D1 (de) 1992-03-12
CN87107852A (zh) 1988-06-22
DE3639418C2 (ja) 1989-08-03
DK385888D0 (da) 1988-07-08
ATE72114T1 (de) 1992-02-15
JP2602043B2 (ja) 1997-04-23
DK385888A (da) 1988-07-08
WO1988003803A1 (en) 1988-06-02

Similar Documents

Publication Publication Date Title
DK173353B1 (da) Kapsel med nikotinholdigt flydende medium til oral indtagelse
US6893654B2 (en) Two-stage transmucosal medicine delivery system for symptom relief
US20220304980A1 (en) Metered dosing compositions and methods of use of psychedelic compounds
US5783207A (en) Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5824334A (en) Tobacco substitute
US20060162732A1 (en) Method for making a nicotine toothpick
US20030008005A1 (en) Sublingual administration of dihydroergotamine for the treatment of migraine
US6645470B1 (en) Treatment and system for nicotine withdrawal
NL2018504B1 (en) Tobacco- and smoke-less products consumable by humans as epicurean or medical products and method of treating smoking addiction
ES2247598T3 (es) Sustitutivo del tabaco.
JP2003535130A (ja) ジメチルスルホンの経口投与によるいびきの管理
DK175773B1 (da) Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler
Dixon The tobacco habit
NO319057B1 (no) Selektive fjernbare nikotin-inneholdende doseringsformer for anvendelse i transmukosal avlevering av nikotin og fremstilling derav.
US9226944B2 (en) Herbal preparation for sleep apnea relief
US3244180A (en) Smoking article combination
Chauhan et al. Nicotine replacement therapy for smoking cessation
US20050045197A1 (en) Multiple drug delivery system & method
US20190133926A1 (en) Burn Pill Pharmaceutical Smoking Cylinder
US20220175755A1 (en) Methods of treating tobacco smoking addiction, and treating nicotine and tobacco smoking addiction
Esha et al. Smoking Cessation: A Review
US20040115244A1 (en) Methods and compositions for nicotine replacement therapy
WO2006004418A2 (en) Encapsulated tobacco smoke
ARORA et al. Targeting Nicotine Addiction-The Possibility of a Healthier Future
Panda et al. Pharmacotherapeutic Approaches in Tobacco Cessation and its Challenges: A Review.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK